Bliss GVS Pharma Limited has informed the Exchange about Credit Rating- New rating received from ICRA Limited
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma Limited has received new credit ratings from ICRA Limited for its fund-based and non-fund-based facilities totaling Rs. 100 crore. ICRA assigned a long-term rating of [ICRA]A-(Stable) and short-term rating of [ICRA]A2+ to the company. These ratings indicate strong creditworthiness with stable outlook for long-term obligations and good capacity for short-term debt repayment. The rating was assigned on April 7-8, 2026, and will be subject to surveillance within one year. The company had facilities with Federal Bank Limited rated under this arrangement.
The A- (Stable) rating is an investment-grade rating suggesting low credit risk and strong debt servicing capability. This positive credit assessment could improve the company's ability to negotiate favourable borrowing terms and enhance investor confidence.